NCT01541475 - Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Major Depressive Disorder

Interventions

DRUG

Bupropion, Escitalopram

Week 0-1: Escitalopram 10mg, Bupropion 150mg Week 2-3: Escitalopram 10mg, Bupropion 300mg Week 4-8: Escitalopram 20mg, Bupropion 300mg

DRUG

Escitalopram

Week 0-3: Escitalopram 10mg Week 4-8: Escitalopram 20mg

Trial Locations (1)

Seoul National University Hospital, Biomedical Research Institute, Seoul